Mutual Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.54M | Buy |
3,275
+191
| +6% | +$89.7K | 0.04% | 378 |
|
|
2025
Q1 | $1.52M | Sell |
3,084
-139
| -4% | -$68.6K | 0.04% | 347 |
|
|
2024
Q4 | $1.34M | Sell |
3,223
-487
| -13% | -$203K | 0.04% | 390 |
|
|
2024
Q3 | $1.75M | Buy |
3,710
+21
| +0.6% | +$9.91K | 0.05% | 306 |
|
|
2024
Q2 | $1.84M | Buy |
3,689
+433
| +13% | +$216K | 0.06% | 292 |
|
|
2024
Q1 | $1.36M | Sell |
3,256
-64
| -2% | -$26.8K | 0.04% | 379 |
|
|
2023
Q4 | $1.35M | Buy |
3,320
+271
| +9% | +$110K | 0.05% | 369 |
|
|
2023
Q3 | $1.06M | Sell |
3,049
-80
| -3% | -$27.8K | 0.04% | 407 |
|
|
2023
Q2 | $1.1M | Buy |
3,129
+171
| +6% | +$60.2K | 0.04% | 410 |
|
|
2023
Q1 | $932K | Sell |
2,958
-88
| -3% | -$27.7K | 0.04% | 441 |
|
|
2022
Q4 | $880K | Sell |
3,046
-27
| -0.9% | -$7.8K | 0.04% | 439 |
|
|
2022
Q3 | $890K | Sell |
3,073
-354
| -10% | -$103K | 0.05% | 399 |
|
|
2022
Q2 | $966K | Sell |
3,427
-4
| -0.1% | -$1.13K | 0.06% | 344 |
|
|
2022
Q1 | $895K | Buy |
3,431
+48
| +1% | +$12.5K | 0.05% | 409 |
|
|
2021
Q4 | $743K | Buy |
3,383
+147
| +5% | +$32.3K | 0.04% | 476 |
|
|
2021
Q3 | $587K | Buy |
3,236
+2
| +0.1% | +$363 | 0.03% | 499 |
|
|
2021
Q2 | $652K | Buy |
3,234
+2,300
| +246% | +$464K | 0.04% | 458 |
|
|
2021
Q1 | $201K | Buy |
+934
| New | +$201K | 0.01% | 735 |
|
|
2020
Q3 | – | Sell |
-2,208
| Closed | -$641K | – | 709 |
|
|
2020
Q2 | $641K | Buy |
+2,208
| New | +$641K | 0.06% | 317 |
|
|
2020
Q1 | – | Sell |
-1,105
| Closed | -$242K | – | 642 |
|
|
2019
Q4 | $242K | Buy |
+1,105
| New | +$242K | 0.03% | 519 |
|